I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Banerji, U.
287
results:
Search for persons
X
Format
Online (287)
Mediatypes
Articles (Online) (62)
OpenAccess-fulltext (225)
Sorted by: Relevance
Sorted by: Year
?
1
A first-in-human phase I study of the PD-1 inhibitor, retif..:
Lakhani, N.
;
Cosman, R.
;
Banerji, U.
...
ESMO Open. 9 (2024) 4 - p. 102254 , 2024
Link:
https://doi.org/10.1016/..
?
2
78P Implementing the modified partial order time-to-event c..:
Hu, X.
;
Banerji, U.
;
Yap, C.
ESMO Open. 9 (2024) - p. 102306 , 2024
Link:
https://doi.org/10.1016/..
?
3
134P A phase I study exploring the safety and tolerability ..:
Pinato, D.J.
;
Banerji, U.
;
Rottey, S.
...
Immuno-Oncology and Technology. 20 (2023) - p. 100606 , 2023
Link:
https://doi.org/10.1016/..
?
4
The paradox-breaking panRAF plus SRC family kinase inhibito..:
Saturno, G.
;
Lopes, F.
;
Niculescu-Duvaz, I.
...
Annals of Oncology. 32 (2021) 2 - p. 269-278 , 2021
Link:
https://doi.org/10.1016/..
?
5
A phase I dose-escalation study of enzalutamide in combinat..:
Kolinsky, M.P.
;
Rescigno, P.
;
Bianchini, D.
...
Annals of Oncology. 31 (2020) 5 - p. 619-625 , 2020
Link:
https://doi.org/10.1016/..
?
6
PATRIOT: A phase I study to assess the tolerability, safety..:
Dillon, M.T.
;
Boylan, Z.
;
Smith, D.
...
Clinical and Translational Radiation Oncology. 12 (2018) - p. 16-20 , 2018
Link:
https://doi.org/10.1016/..
?
7
PO-498 Quantifying the dynamics of acquired treatment resis..:
Acar, A.
;
Nichol, D.
;
Thavasu, P.
...
ESMO Open. 3 (2018) - p. A217 , 2018
Link:
https://doi.org/10.1136/..
?
8
Vistusertib (dual m-TORC1/2 inhibitor) in combination with ..:
Basu, B.
;
Krebs, M.G.
;
Sundar, R.
...
Annals of Oncology. 29 (2018) 9 - p. 1918-1925 , 2018
Link:
https://doi.org/10.1093/..
?
9
Clinical Outcome of Patients with Advanced Biliary Tract Ca..:
Sundar, R.
;
Custodio, A.
;
Petruckevich, A.
...
Clinical Oncology. 30 (2018) 3 - p. 185-191 , 2018
Link:
https://doi.org/10.1016/..
?
10
Phase I trial outcomes in older patients with advanced soli..:
Khan, K H
;
Yap, T A
;
Ring, A
...
British Journal of Cancer. 114 (2016) 3 - p. 262-268 , 2016
Link:
https://doi.org/10.1038/..
?
11
A phase I/II trial of AT9283, a selective inhibitor of auro..:
Vormoor, B.
;
Veal, G. J.
;
Griffin, M. J.
...
Pediatric Blood & Cancer. 64 (2016) 6 - p. e26351 , 2016
Link:
https://doi.org/10.1002/..
?
12
Titration of signalling output: insights into clinical comb..:
Stewart, A.
;
Thavasu, P.
;
de Bono, J.S.
.
Annals of Oncology. 26 (2015) 7 - p. 1504-1510 , 2015
Link:
https://doi.org/10.1093/..
?
13
343 Translational phase I trial combining the AKT inhibitor..:
Michalarea, V.
;
Lopez, J.
;
Lorente, D.
...
European Journal of Cancer. 51 (2015) - p. S68 , 2015
Link:
https://doi.org/10.1016/..
?
14
339 Clinical outcome and prognostic factors of patients (pt..:
Papadatos-Pastos, D.
;
Roda, D.
;
Luken, M. De Miguel
...
European Journal of Cancer. 51 (2015) - p. S67 , 2015
Link:
https://doi.org/10.1016/..
?
15
333 Phase I dose-escalation trial with the DNA-alkylating a..:
Van Herpen, C.M.
;
Banerji, U.
;
Mommers, E.C.
...
European Journal of Cancer. 51 (2015) - p. S65 , 2015
Link:
https://doi.org/10.1016/..
1-15